HDAC9 and plasma cell myeloma: In conclusion, our findings underscore the critical role of glutaminolysis in myeloma cell proliferation and highlight the efficacy of GLS inhibitors in targeting myeloma cells while enhancing the cytotoxic effects of HDAC inhibitors.